Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Myasthenia Gravis Awareness Month

  • Home Blog Myasthenia gravis awareness month

Myasthenia Gravis Awareness Month

Jun 28, 2019

Myasthenia Gravis

June is Myasthenia Gravis Awareness Month.
Myasthenia gravis is a disorder causing weakness and easy fatigue of voluntary muscles. It is caused by a breakdown in the communication between nerves and muscles, usually because of an immunological problem.

Downloads

Article in PDF

Recent Articles
  1. Statistical Insight on Some Common Cancers
  2. World Ovarian Cancer Day | 2019
  3. Eisai Submits Marketing Authorization Application for Tasurgratinib; CHMP Issues Positive Opinion...
  4. World Diabetes Day | 2019
  5. World Brain Tumor Day
fcrn-inhibitors-in-20-indications
Articles

FcRn Inhibitors Being The Fastest Growing Class, Plans To Get Explored In 20+ Indications

pharma-news-for-astrazeneca-daiichi-sankyo-basilea-genmab
Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca and Daiichi Sankyo’s Enhertu US Approval; Basilea’s ZEVTERA FDA Approval; Genmab’s ProfoundBio Acquisition; Rocket Pharmaceuticals’ RP-L102 EMA Approval; Alexion’s Ultomiris and Soliris AAN 2024 Data

Pharma News for Eisai, Biogen, Merck, BMS, Kyverna
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Eisai Submits Marketing Authorization Application for Tasurgratinib; CHMP Issues Positive Opinion for Biogen’s SKYCLARYS; European Commission Approves Merck’s KEYTRUDA + Chemotherapy HER2-ve Gastric or GEJ Adenocarcinoma; BMS Provides Update on RELATIVITY-123 Trial; Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101; Verrica and Torii Pharma Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208

myasthenia gravis
Myasthenia Gravis Awareness Month
WHO
loader